These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 11565217)

  • 41. Severe outbreak of meningococcal disease in Auckland.
    Jackson G; Lennon D; Voss L; Flight R
    N Z Med J; 1987 Apr; 100(821):226. PubMed ID: 3455492
    [No Abstract]   [Full Text] [Related]  

  • 42. Meningococcus C vaccination programme.
    Murphy JF
    Ir Med J; 2000 Sep; 93(6):164. PubMed ID: 11105434
    [No Abstract]   [Full Text] [Related]  

  • 43. New guidelines for management and prevention of meningococcal disease in Australia. Meningococcal Disease Working Party of the National Health and Medical Research Council.
    Patel MS; Collignon PJ; Watson CR; Condon RJ; Doherty RR; Merianos A; Stewart GJ
    Med J Aust; 1997 Jun; 166(11):598-601. PubMed ID: 9201182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Were the meningococcal vaccination campaigns in 1974-76 of benefit?].
    Peltola H; Nors T; Salminen S; Käyhty H; Sivonen A; Jousimies-Somer H; Mäkelä P
    Duodecim; 1983; 99(5):332-41. PubMed ID: 6872895
    [No Abstract]   [Full Text] [Related]  

  • 45. Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998.
    Squires SG; Pelletier L; Mungai M; Tsang R; Collins F; Stoltz J
    Can Commun Dis Rep; 2000 Nov; 26(21):177-82. PubMed ID: 11107657
    [No Abstract]   [Full Text] [Related]  

  • 46. Meningococcal vaccines: a neglected topic in travel medicine?
    Wilder-Smith A
    Expert Rev Vaccines; 2009 Oct; 8(10):1343-50. PubMed ID: 19803757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients].
    de Greeff SC; de Melker HE; Spanjaard L; van den Hof S; Dankert J
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1132-5. PubMed ID: 12822525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neisseria meningitidis carriage during an outbreak of serogroup C disease.
    Patrick DM; Champagne S; Goh SH; Arsenault G; Thomas E; Shaw C; Rahim T; Taha F; Bigham M; Dubenko V; Skowronski D; Brunham RC
    Clin Infect Dis; 2003 Nov; 37(9):1183-8. PubMed ID: 14557962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Public health management in invasive meningococcal diseases].
    Ehrhard I; Arndt U
    Gesundheitswesen; 2004 Dec; 66(12):790-5. PubMed ID: 15609213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Meningococcal disease in children hospitalized at six Canadian pediatric tertiary care centres.
    Gold R; Déry P; Halperin S; Law B; MacDonald N; Scheifele D; Marchessault V; Duclos P
    Can Commun Dis Rep; 1994 Jan; 20(2):9-11; discussion 11-2. PubMed ID: 8161973
    [No Abstract]   [Full Text] [Related]  

  • 51. New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery.
    Dyet K; Devoy A; McDowell R; Martin D
    Vaccine; 2005 Mar; 23(17-18):2228-30. PubMed ID: 15755601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The 2001 serological survey in the Czech Republic--invasive meningococcal disease.
    Krízová P
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S62-7. PubMed ID: 15080262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The 2006 Childhood and Adolescent Immunization Schedule: reflections at the 50th anniversary of the polio vaccine.
    Temte JL
    Am Fam Physician; 2006 Jan; 73(1):37, 40. PubMed ID: 16417063
    [No Abstract]   [Full Text] [Related]  

  • 54. Serogroup B meningococcal disease during Hajj: preparing for the worst scenario.
    Khalil MK; Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):231-4. PubMed ID: 19717106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meningococcal disease--prevention and intervention.
    Meeker J
    Ohio Nurses Rev; 2002 Jul; 77(6):15-8; quiz 18-9. PubMed ID: 15133878
    [No Abstract]   [Full Text] [Related]  

  • 56. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians.
    Kafetzis DA; Stamboulidis KN; Tzanakaki G; Kourea Kremastinou J; Skevaki CL; Konstantopoulos A; Tsolia M
    Clin Microbiol Infect; 2007 May; 13(5):550-2. PubMed ID: 17378929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Guidelines for controlling meningococcal disease.
    CMAJ; 1992 Mar; 146(6):939-42, 945-8. PubMed ID: 1544081
    [No Abstract]   [Full Text] [Related]  

  • 58. Meningococcal infections-research and basis for control measures in Norway. A summarizing discussion of main topics from a symposium held on 29 April 1980 in Oslo.
    Bøvre K
    NIPH Ann; 1980 Dec; 3(2):109-25. PubMed ID: 6784040
    [No Abstract]   [Full Text] [Related]  

  • 59. MeNZB vaccine and epidemic control: when do you stop vaccinating?
    Loring BJ; Turner N; Petousis-Harris H
    Vaccine; 2008 Nov; 26(47):5899-904. PubMed ID: 18804134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.